Wart war: vitamin D3 or acyclovir injections – which works better?
NCT ID NCT07448844
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting acyclovir (an antiviral drug) or vitamin D3 directly into skin warts can clear them. Forty people aged 12 and older with common, plantar, flat, or nail warts will receive injections every two weeks for up to four sessions. The main goal is to see which treatment leads to complete wart clearance by week 8.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
acyclovir or vitamin D3 injected into the wart
What this could lead to
If it works, this could point toward a simple, affordable injection treatment for common skin warts.
What could go wrong
This is a small, early-phase trial with only 40 people, so results may not apply to everyone. Warts may come back, and injections can be painful or cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLANTAR WART are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Railway General Hospital, Railway Carriage Factory Rd, Railway Scheme 7, Rawalpindi
RECRUITINGRawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Riphah International Hospital, Islamabad Expy, Sector A DHA Phase 5, Islamabad
RECRUITINGIslamabad, 44000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact